Rising bowel cancer cases in young Australians and precision medicine breakthroughs
Consensus Summary
Alarmingly rising cases of bowel cancer among young Australians, particularly those in their 30s, are being reported, with incidence up 137% since 2000. Nathan Borg, a 29-year-old diagnosed with bowel cancer three months before his wedding, became a case study for precision medicine after genomic testing revealed his tumor was MSI-high, a rare but treatable mutation. Borg’s cancer was linked to Lynch syndrome, an inherited condition, and he responded well to immunotherapy, becoming cancer-free by January 2026. Experts like David Thomas of Omico emphasize the need to understand environmental or dietary factors contributing to early-onset colorectal cancer, while Cancer Australia’s CEO, Professor Dorothy Keefe, warns against lowering the screening age due to cost and potential delays in diagnosis. Both sources agree that young people should monitor symptoms like blood in stools or unexplained weight loss and consult their GP promptly. Cancer Australia and the National Health and Medical Research Council are funding research into early-onset colorectal cancer risk factors, tests, and treatments, reflecting the growing urgency of the issue.
✓ Verified by 2+ sources
Key details reported by multiple sources:
- Nathan Borg, a 29-year-old project manager, was diagnosed with bowel cancer in 2026, three months before his wedding, after a colonoscopy revealed a tumor.
- Bowel cancer incidence in Australians aged 30s has risen 137% since 2000, from 184 cases in 2000 to an estimated 772 in 2025.
- About 1 in 6 bowel cancer patients have tumors with a genomic quirk (microsatellite instability, or MSI) making them highly sensitive to immunotherapies.
- Up to 15% of colorectal cancers exhibit MSI, which occurs when DNA mismatch repair proteins fail to fix errors in short DNA sequences.
- Borg’s cancer was MSI-high, detected through genomic testing after standard MSI testing failed to identify it due to his specific gene mutation.
- Borg was diagnosed with Lynch syndrome, an inherited genetic condition accounting for up to 15% of MSI-high colorectal cancers (SMH says 3%, but THEAGE says 15%).
- Borg underwent a two-year course of PBS-funded immunotherapy drug pembrolizumab and has been cancer-free since January 2026.
- Cancer Australia’s CEO, Professor Dorothy Keefe, urged young people to see their GP if they notice blood in stools, changes in bowel habits, or unexplained symptoms like pain, vomiting, or weight loss.
- Cancer Australia and the National Health and Medical Research Council announced three projects focusing on early-onset colorectal cancer risk factors, tests, and treatments on May 10, 2026.
- David Thomas, founder and chief scientist of Omico, stated that bowel cancer in young Australians is still uncommon but rising, and survival rates are improving.
Points of Difference
Details reported by only one source:
- Borg’s cancer was one of the subset of patients (~1 in 6) with tumors exquisitely sensitive to immunotherapies, as described by a global leader in precision oncology.
- An analysis of Omico’s database found that 14 patients were diagnosed with bowel cancer before they turned 25.
- Cancer Australia’s CEO, Professor Dorothy Keefe, argued that lowering the bowel cancer screening age would cost an enormous amount of money and could delay diagnoses by clogging colonoscopy waiting lists.
- Cancer Australia has commissioned an evidence review of early-onset cancer risk factors, with updated guidelines reflecting how young people present with cancer.
- Borg had no trouble tolerating the PBS-funded immunotherapy drug pembrolizumab for his two-year course, and he and his fiancée Samantha are expecting their first child in August 2026.
- Lynch syndrome accounts for about 3% of colorectal cancers with MSI (THEAGE says 15%).
Contradictions
Conflicting information between sources:
- THEAGE states Lynch syndrome accounts for up to 15% of MSI-high colorectal cancers, while SMH states it accounts for about 3%.
- THEAGE mentions that Borg lost his hair twice during chemotherapy, while SMH does not include this detail.
Source Articles
This cancer is rising in young people like Nathan. There are ‘exquisite’ reasons not to despair
A quirk in these tumours could be the key to survival.
This cancer is rising in young people like Nathan. There are ‘exquisite’ reasons not to despair
A quirk in these tumours could be the key to survival.